London, UK; 14 March 2016: GW Pharmaceuticals plc (Nasdaq: GWPH, AIM: “GWP,” “GW,” “the Company” or “the Group”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announces the positive results of the first pivotal Phase 3 study of its investigational medicine Epidiolex® (cannabidiol or CBD) for […]
On April 1st – April 3rd, the EFEPA participated in the Epilepsy Foundation of America’s annual Kids Speak Up! This program is the centerpiece advocacy initiative with over 250 advocates, including other Epilepsy Foundation affiliate staff, parents, children, doctors and volunteers that come from across the nation to share their story, raise awareness, and discuss […]
Dear Pennsylvania Epilepsy Advocates,
You’ve done it! You helped to ensure that funding for epilepsy services in Pennsylvania will continue throughout next year. The final state budget enacted by Pennsylvania does include a specific line item for epilepsy services and $390,000 in state funding for epilepsy programs.
Congratulations to all of the […]